NCT02444442View on ClinicalTrials.gov

Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Hypertension
Interventions
DEVICE

Renal Denervation

Deliberate disruption of the renal nerves via radio frequency energy delivery to renal arteries.

OTHER

Sham control

Arterial access only. No delivery of radio frequency energy to renal arteries.

Trial Locations (1)

3004

Baker IDI Heart & Diabetes Institute, Melbourne

All Listed Sponsors
lead

Baker Heart and Diabetes Institute

OTHER

NCT02444442 - Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension | Biotech Hunter | Biotech Hunter